[1] MALEKJAHANI A, SINDHWANI S, SYED A M et al. Engineering steps for mobile point-of-care diagnostic devices[J]. Accounts of Chemical Research, 2406-2414(2019).

[2] HE H, LIU L, MORIN E E et al. Survey of clinical translation of cancer nanomedicines—lessons learned from successes and failures[J]. Accounts of Chemical Research, 2445-2461(2019).

[3] HUANG H, FENG W, CHEN Y et al. Inorganic nanoparticles in clinical trials and translations[J]. Nano Today(2020).

[4] HUANG H, FENG W, CHEN Y. Two-dimensional biomaterials: material science, biological effect and biomedical engineering applications[J]. Chemical Society Reviews, 11381-11485(2021).

[5] PELAZ B, ALEXIOU C H, ALVAREZ-PUEBLA R A et al. Diverse applications of nanomedicine[J]. ACS Nano, 2313-2381(2017).

[6] BURDA C, CHEN X, NARAYANAN R et al. Chemistry and properties of nanocrystals of different shapes[J]. Chemical Reviews, 1025-1102(2005).

[7] XIANG H, CHEN Y. Materdicine: interdiscipline of materials and medicine[J]. VIEW, 20200016-29(2020).

[8] SHI J J, KANTOFF P W, WOOSTER R et al. Cancer nanomedicine: progress, challenges and opportunities[J]. Nature Reviews Cancer, 20-37(2017).

[9] IRBY D, DU C, LI F. Lipid-drug conjugate for enhancing drug delivery[J]. Molecular Pharmaceutics, 1325-1338(2017).

[10] MURA S, NICOLAS J, COUVREUR P. Stimuli-responsive nanocarriers for drug delivery[J]. Nature Materials, 991-1003(2013).

[11] NICOLAS J, MURA S, BRAMBILLA D et al. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery[J]. Chemical Society Reviews, 1147-1235(2013).

[12] KUNJACHAN S, EHLING J, STORM G et al. Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects[J]. Chemical Reviews, 10907-10937(2015).

[13] CHEN H M, ZHANG W Z, ZHU G Z et al. Rethinking cancer nanotheranostics[J]. Nature Reviews Materials, 17024-18(2017).

[14] WANG C, HUANG W, ZHOU Y et al. 3D printing of bone tissue engineering scaffolds[J]. Bioactive Materials, 82-91(2020).

[15] KAUR B, KUMAR S, KAUSHIK B K. Recent advancements in optical biosensors for cancer detection[J]. Biosensors and Bioelectronics(2022).

[16] HUH A J, KWON Y J. “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.[J]. Journal of Controlled Release, 128-145(2011).

[17] DUAN Y, LIU B. Recent advances of optical imaging in the second near-infrared window[J]. Advanced Materials, 1802394-19(2018).

[18] HUANG L Y, ZHU S, CUI R et al. Noninvasive in vivo imaging in the second near-infrared window by inorganic nanoparticle-based fluorescent probes[J]. Analytical Chemistry, 535-542(2019).

[19] LIN H, GAO S, DAI C et al. A two-dimensional biodegradable niobium carbide (MXene) for photothermal tumor eradication in NIR-I and NIR-II biowindows[J]. Journal of the American Chemical Society, 16235-16247(2017).

[20] YANG Q, HU Z, ZHU S et al. Donor engineering for NIR-II molecular fluorophores with enhanced fluorescent performance[J]. Journal of the American Chemical Society, 1715-1724(2018).

[21] YANG H C, LI R F, ZHANG Y J et al. Colloidal alloyed quantum dots with enhanced photoluminescence quantum yield in the NIR-II window[J]. Journal of the American Chemical Society, 2601-2607(2021).

[22] FAN Y, WANG S, ZHANG F. Optical multiplexed bioassays for improved biomedical diagnostics[J]. Angewandte Chemie International Edition, 13342-13353(2019).

[23] WELSHER K, LIU Z, SHERLOCK SP et al. A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice[J]. Nature Nanotechnology, 773-780(2009).

[24] CHANG B, LI D, REN Y et al. A phosphorescent probe for in vivo imaging in the second near-infrared window[J]. Nature Biomedical Engineering, 629-639(2022).

[25] WANG Q, LIANG Z, LI F et al. Dynamically switchable magnetic resonance imaging contrast agents[J]. Exploration, 20210009-8(2021).

[26] KIM D, KIM J, PARK Y I et al. Recent development of inorganic nanoparticles for biomedical imaging[J]. ACS Central Science, 324-336(2018).

[27] XU Z, LIU C, ZHAO S et al. Molecular sensors for NMR-based detection[J]. Chemical Reviews, 195-230(2018).

[28] CHO M H, SHIN S H, PARK S H et al. Targeted, stimuli-responsive, and theranostic ¹⁹F magnetic resonance imaging probes[J]. Bioconjugate Chemistry, 2502-2518(2019).

[29] ZHAO X, DUAN G, WU K et al. Intelligent metamaterials based on nonlinearity for magnetic resonance imaging[J]. Advanced Materials, 1905461-7(2019).

[30] DELCASSIAN D, LUZHANSKY I, SPANOUDAKI V et al. Magnetic retrieval of encapsulated beta cell transplants from diabetic mice using dual-function MRI visible and retrievable microcapsules[J]. Advanced Materials, 1904502-10(2020).

[31] ZHANG J, YUAN Y, GAO M et al. Carbon dots as a new class of diamagnetic chemical exchange saturation transfer (diacest) MRI contrast agents[J]. Angewandte Chemie International Edition, 9871-9875(2019).

[32] ZHANG P, HOU Y, ZENG J et al. Coordinatively unsaturated Fe³⁺ based activatable probes for enhanced MRI and therapy of tumors[J]. Angewandte Chemie International Edition, 11088(2019).

[33] DAI C, CHEN Y, JING X X et al. Two-dimensional tantalum carbide (MXenes) composite nanosheets for multiple imaging- guided photothermal tumor ablation[J]. ACS Nano, 12696-12712(2017).

[34] DAI C, LIN H, XU G et al. Biocompatible 2D titanium carbide (MXenes) composite nanosheets for pH-responsive MRI-guided tumor hyperthermia[J]. Chemistry of Materials, 8637-8652(2017).

[35] LIU Z, LIN H, ZHAO M L et al. 2D superparamagnetic tantalum carbide composite MXenes for efficient breast-cancer theranostics[J]. Theranostics, 1648-1664(2018).

[36] LIU Z, ZHAO M L, LIN H et al. 2D magnetic titanium carbide MXene for cancer theranostics[J]. Journal of Materials Chemistry B, 3541-3548(2018).

[37] CAO Y, WU T, ZHANG K et al. Engineered exosome-mediated near-infrared-II region V₂C quantum dot delivery for nucleus-target low-temperature photothermal therapy[J]. ACS Nano, 1499-1510(2019).

[38] BAR-ZION A, NOURMAHNAD A, MITTELSTEIN D R et al. Acoustically triggered mechanotherapy using genetically encoded gas vesicles[J]. Nature Nanotechnology, 1403-1412(2021).

[39] LIU Y, BHATTARAI P, DAI Z et al. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer[J]. Chemical Society Reviews, 2053-2108(2019).

[40] LI X, CAI Z, JIANG L P et al. Metal-ligand coordination nanomaterials for biomedical imaging[J]. Bioconjugate Chemistry, 332-339(2019).

[41] MENG Z, ZHOU X, SHE J et al. Ultrasound-responsive conversion of microbubbles to nanoparticles to enable background-free in vivo photoacoustic imaging[J]. Nano Letters, 8109-8117(2019).

[42] CHEN Y S, ZHAO Y, YOON S J et al. Miniature gold nanorods for photoacoustic molecular imaging in the second near-infrared optical window[J]. Nature Nanotechnology, 465-472(2019).

[43] KIM J, CHHOUR P, HSU J et al. Use of nanoparticle contrast agents for cell tracking with computed tomography[J]. Bioconjugate Chemistry, 1581-1597(2017).

[44] ZHOU B G, YIN H H, DONG C H et al. Biodegradable and excretable 2D W_1.33C i-MXene with vacancy ordering for theory- oriented cancer nanotheranostics in near-infrared biowindow[J]. Advanced Science, 2101043-13(2021).

[45] XU J, SHI R, CHEN G et al. All-in-one theranostic nanomedicine with ultrabright second near-infrared emission for tumor- modulated bioimaging and chemodynamic/photodynamic therapy[J]. ACS Nano, 9613-9625(2020).

[46] JUNG H S, VERWILST P, SHARMA A et al. Organic molecule- based photothermal agents: an expanding photothermal therapy universe[J]. Chemical Society Reviews, 2280-2297(2018).

[47] WANG H, CHANG J, SHI M et al. A dual-targeted organic photothermal agent for enhanced photothermal therapy[M]. Angewandte Chemie International Edition, 1073(2019).

[48] YU Z, HU W, ZHAO H et al. Generating new cross-relaxation pathways by coating prussian blue on NaNdF₄ to fabricate enhanced photothermal agents[J]. Angewandte Chemie International Edition, 8536-8540(2019).

[49] JIANG Y, LI J, ZHEN X et al. Dual-peak absorbing semiconducting copolymer nanoparticles for first and second near-infrared window photothermal therapy: a comparative study[J]. Advanced Materials, 1705980-7(2018).

[50] ZHEN X, XIE C, PU K. Temperature-correlated afterglow of a semiconducting polymer nanococktail for imaging-guided photothermal therapy[M]. Angewandte Chemie International Edition, 4006(2018).

[51] SMITH A M, MANCINI M C, NIE S. Second window for in vivo imaging[J]. Nature Nanotechnology, 710-711(2009).

[52] ZHOU J, JIANG Y, HOU S et al. Compact plasmonic blackbody for cancer theranosis in the near-infrared II window[J]. ACS Nano, 2643-2651(2018).

[53] CHENG Y, YANG F, XIANG G et al. Ultrathin tellurium oxide/ ammonium tungsten bronze nanoribbon for multimodality imaging and second near-infrared region photothermal therapy[J]. Nano Letters, 1179-1189(2019).

[54] CUI J, JIANG R, GUO C et al. Fluorine grafted Cu₇S₄-Au heterodimers for multimodal imaging guided photothermal therapy with high penetration depth[J]. Journal of the American Chemical Society, 5890-5894(2018).

[55] SUN S, SONG Y, CHEN J et al. NIR-I and NIR-II irradiation tumor ablation using NbS₂ nanosheets as the photothermal agent[J]. Nanoscale, 18300-18310(2021).

[56] XIANG H J, CHEN Y. Energy-converting nanomedicine[J]. Small, 1805339-31(2019).

[57] HU H, QIAN X Q, CHEN Y. Microalgae-enabled photosynthetic alleviation of tumor hypoxia for enhanced nanotherapies[J]. Science Bulletin, 1869-1871(2020).

[58] CHEN B D, XIANG H J, PAN S S et al. Advanced theragenerative biomaterials with therapeutic and regeneration multifunctionality[J]. Advanced Functional Materials, 2002621-27(2020).

[59] FENG W, CHEN Y. Chemoreactive nanomedicine[J]. Journal of Materials Chemistry B, 6753-6764(2020).

[60] LUCKY S S, SOO K C, ZHANG Y. Nanoparticles in photodynamic therapy[J]. Chemical Reviews, 1990-2042(2015).

[61] CHANG M, FENG W, DING L et al. Persistent luminescence phosphor as in-vivo light source for tumoral cyanobacterial photosynthetic oxygenation and photodynamic therapy[J]. Bioactive Materials(2022).

[62] ZHOU L, DONG C, DING L et al. Targeting ferroptosis synergistically sensitizes apoptotic sonodynamic anti-tumor nanotherapy[J]. Nano Today(2021).

[63] SHEN Y, CHEN L, GUAN X et al. Tailoring chemoimmunostimulant bioscaffolds for inhibiting tumor growth and metastasis after incomplete microwave ablation[J]. ACS Nano, 20414-20429(2021).

[64] MELLMAN I, COUKOS G, DRANOFF G. Cancer immunotherapy comes of age.[J]. Nature, 480-489(2011).

[65] RIBAS A, WOLCHOK J D. Cancer immunotherapy using checkpoint blockade[J]. Science, 1350-1355(2018).

[66] MAHONEY K M, RENNERT P D, FREEMAN G J. Combination cancer immunotherapy and new immunomodulatory targets[J]. Nature Reviews Drug Discovery, 561-584(2015).

[67] VANNEMAN M, DRANOFF G. Combining immunotherapy and targeted therapies in cancer treatment[J]. Nature Reviews Cancer, 237-251(2012).

[68] SANG W, ZHANG Z, DAI Y et al. Recent advances in nanomaterial-based synergistic combination cancer immunotherapy[J]. Chemical Society Reviews, 3771-3810(2019).

[69] SHIELDS IV CW, WANG L W, EVANS M A et al. Materials for immunotherapy[J]. Advanced Materials, 1901633-56(2020).

[70] NAM J, SON S, PARK K S et al. Cancer nanomedicine for combination cancer immunotherapy[J]. Nature Reviews Materials, 398-414(2019).

[71] SONG W, MUSETTI S N, HUANG L. Nanomaterials for cancer immunotherapy[J]. Biomaterials(2017).

[72] CHEUNG A S, MOONEY D J. Engineered materials for cancer immunotherapy[J]. Nano Today, 511-531(2015).

[73] LIU Y, WANG L, SONG Q et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti- PD-L1 therapy for malignant pleural effusion[J]. Nature Nanotechnology, 206-216(2022).

[74] ZHENG Y, LI X, DONG C et al. Ultrasound-augmented nanocatalytic ferroptosis reverses chemotherapeutic resistance and induces synergistic tumor nanotherapy[J]. Advanced Functional Materials, 2107529-17(2022).

[75] XU W, DONG C, HU H et al. Engineering Janus chemoreactive nanosonosensitizers for bilaterally augmented sonodynamic and chemodynamic cancer nanotherapy[J]. Advanced Functional Materials, 2103134-13(2021).

[76] XIANG H, YOU C, LIU W et al. Chemotherapy-enabled /augmented cascade catalytic tumor-oxidative nanotherapy[J]. Biomaterials(2021).

[77] WANG H X, LI M, LEE C M et al. CRISPR/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery[J]. Chemical Reviews, 9874-9906(2017).

[78] LYU Y, HE S S, LI J C et al. A photolabile semiconducting polymer nanotransducer for near-infrared regulation of CRISPR/ Cas9 gene editing[J]. Angewandte Chemie International Edition, 18197-18201(2019).

[79] CHENG Q, WEI T, FARBIAK L et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing[J]. Nature Nanotechnology, 313-320(2020).

[80] YIN H, ZHOU B, DONG C et al. CRISPR/Cas9-2D silicene gene-editing nanosystem for remote NIR-II-induced tumor microenvironment reprogramming and augmented photonic tumor ablation[J]. Advanced Functional Materials, 2107093-12(2021).

[81] YIN H, SUN L, PU Y et al. Ultrasound-controlled CRISPR/Cas9 system augments sonodynamic therapy of hepatocellular carcinoma[J]. ACS Central Science, 2049-2062(2021).

[82] LI M, MA H, HAN F et al. Microbially catalyzed biomaterials for bone regeneration[J]. Advanced Materials, 2104829-13(2021).

[83] ZHOU Y, WU C, CHANG J. Bioceramics to regulate stem cells and their microenvironment for tissue regeneration[J]. Materials Today(2019).

[84] LI T, CHANG J, ZHU Y et al. 3D printing of bioinspired biomaterials for tissue regeneration[J]. Advanced Healthcare Materials, 2000208-17(2020).

[85] STEVENS M M. Biomaterials for bone tissue engineering[J]. Materials Today, 18-25(2008).

[86] DISCHER D E, MOONEY D J, ZANDSTRA P W. Growth factors, matrices, and forces combine and control stem cells[J]. Science, 1673-1677(2009).

[87] GEIGER B, SPATZ J P, BERSHADSKY A D. Environmental sensing through focal adhesions[J]. Nature Reviews Molecular Cell Biology, 21-33(2009).

[88] WANG L, YANG Q, HUO M et al. Engineering single-atomic iron-catalyst-integrated 3D-printed bioscaffolds for osteosarcoma destruction with antibacterial and bone defect regeneration bioactivity[J]. Advanced Materials, 2100150-12(2021).

[89] SOMMARIVA M, LE NOCI V, BIANCHI F et al. The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy[J]. Cellular and Molecular Life Sciences, 2739-2749(2020).

[90] YANG W, PETERS J I, WILLIAMS R O. Inhaled nanoparticles-a current review[J]. International Journal of Pharmaceutics, 239-247(2008).

[91] MYERSON J W, PATEL P N, RUBEY K M et al. Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation[J]. Nature Nanotechnology, 86-97(2022).

[92] VASARMIDI E, TSITOURA E, SPANDIDOS D A et al. Pulmonary fibrosis in the aftermath of the COVID-19 era.[J]. Experimental and Therapeutic Medicine, 2557-2560(2020).

[93] CRISAN-DABIJA R, PAVEL C A, POPA I V et al. “A chain only as strong as its weakest link”: an up-to-date literature review on the bidirectional interaction of pulmonary fibrosis and COVID-19[J]. Journal of Proteome Research, 4327-4338(2020).

[94] LEDERER D J, MARTINEZ F J. Idiopathic pulmonary fibrosis[J]. New England Journal of Medicine, 1811-1823(2018).

[95] RICHELDI L, COLLARD H R, JONES M G. Idiopathic pulmonary fibrosis[J]. Lancet, 1941-1952(2017).

[96] MERKT W, BUENO M, MORA AL et al. Senotherapeutics: targeting senescence in idiopathic pulmonary fibrosis[J]. Seminars in Cell & Developmental Biology(2020).

[97] MALSIN E S, KAMP D W. The mitochondria in lung fibrosis: Friend or foe[J]. Translational Research(2018).

[98] YU G, TZOUVELEKIS A, WANG R et al. Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function[J]. Nature Medicine, 39-49(2018).

[99] SALEH J, PEYSSONNAUX C, SINGH K K et al. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis[J]. Mitochondrion(2020).

[100] HUANG T, ZHANG T, JIANG X et al. Iron oxide nanoparticles augment the intercellular mitochondrial transfer-mediated therapy[J]. Science Advances, eabj0534-15(2021).

[101] FENG W, HAN X G, HU H et al. 2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases[J]. Nature Communications, 2203-16(2021).

[102] WANG K, ZHANG Y, MAO W et al. Engineering ultrasmall ferroptosis-targeting and reactive oxygen/nitrogen species- scavenging nanozyme for alleviating acute kidney injury[J]. Advanced Functional Materials, 2109221-13(2022).

[103] TANG Z, HUO M, JU Y et al. Nanoprotection against retinal pigment epithelium degeneration via ferroptosis inhibition[J]. Small Methods, 2100848-14(2021).

[104] WU J, YUK H, SARRAFIAN TIFFANY L et al. An off-the-shelf bioadhesive patch for sutureless repair of gastrointestinal defects[J]. Science Translational Medicine, eabh2857-13.

[105] KIM S J, CHOI S J, JANG J S et al. Innovative nanosensor for disease diagnosis[J]. Accounts of Chemical Research, 1587-1596(2017).

[106] TANG Z M, KONG N, ZHANG X C et al. A materials-science perspective on tackling COVID-19[J]. Nature Reviews Materials, 847-860(2020).

[107] FAROKHZAD N, TAO W. Materials chemistry-enabled platforms in detecting sexually transmitted infections: progress towards point-of-care tests[J]. Trends in Chemistry, 589-602(2021).

[108] GONG M M, SINTON D. Turning the page: advancing paper-based microfluidics for broad diagnostic application[J]. Chemical Reviews, 8447-8480(2017).

[109] HUANG X, LIU Y, YUNG B et al. Nanotechnology-enhanced no-wash biosensors for in vitro diagnostics of cancer[J]. ACS Nano, 5238-5292(2017).

[110] WANG C, QI B, LIN M et al. Continuous monitoring of deep-tissue haemodynamics with stretchable ultrasonic phased arrays[J]. Nature Biomedical Engineering, 749-758(2021).

[111] CHAIBUN T, PUENPA J, NGAMDEE T et al. Rapid electrochemical detection of coronavirus SARS-Cov-2[J]. Nature Communications, 802-10(2021).

[112] GATES B. Responding to COVID-19-a once-in-a-century pandemic[J]. New England Journal of Medicine, 1677-1679(2020).

[113] LAURING A S, FRYDMAN J, ANDINO R. The role of mutational robustness in RNA virus evolution[J]. Nature Reviews Microbiology, 327-336(2013).

[114] SEO G, LEE G, KIM M J et al. Rapid detection of COVID-19 causative virus (SARS-Cov-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor[J]. ACS Nano, 5135-5142(2020).

[115] XIAO G, HE J, CHEN X et al. A wearable, cotton thread/paper- based microfluidic device coupled with smartphone for sweat glucose sensing[J]. Cellulose, 4553-4562(2019).

[116] LI T, CHEN L, YANG X et al. A flexible pressure sensor based on an MXene-textile network structure[J]. Journal of Materials Chemistry C, 1022-1027(2019).

[117] KALELKAR P P, RIDDICK M, GARCIA A J. Biomaterial-based antimicrobial therapies for the treatment of bacterial infections[J]. Nature Reviews Materials, 39-54(2022).

[118] LI J F, LI Z Y, LIU X M et al. Interfacial engineering of Bi₂S₃/Ti₃C₂T_x MXene based on work function for rapid photo- excited bacteria-killing[J]. Nature Communications, 1224-10(2021).

[119] DURÁN N, DURÁN M, DE JESUS MB et al. Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity[J]. Nanomedicine: Nanotechnology, Biology and Medicine, 789-799(2016).

[120] PANÁČEK A, KVÍTEK L, SMÉKALOVÁ M et al. Bacterial resistance to silver nanoparticles and how to overcome it.[J]. Nature Nanotechnology, 65-71(2018).

[121] STABRYLA L M, JOHNSTON K A, DIEMLER N A et al. Role of bacterial motility in differential resistance mechanisms of silver nanoparticles and silver ions[J]. Nature Nanotechnology, 996-1003(2021).

[122] LI B, WANG W, SONG W et al. Antiviral and anti-inflammatory treatment with multifunctional alveolar macrophage-like nanoparticles in a surrogate mouse model of COVID-19[J]. Advanced Science, 2003556-14(2021).

[123] VALLIERES C, HOOK A L, HE Y et al. Discovery of (meth)acrylate polymers that resist colonization by fungi associated with pathogenesis and biodeterioration[J]. Science Advances, eaba6574-12(2020).